Results 121 to 130 of about 3,477,139 (310)
Internet Securities Fraud: Old Trick, New Medium [PDF]
Billions of securities are traded every day in public and private markets around the world. This practice is hundreds of years old and as long as securities have been traded, someone has tried to defraud the system to make a quick buck.
Fowler, Brendon +2 more
core +1 more source
In this paper we deal with the local null controllability of the N-dimensional Navier-Stokes system with internal controls having one vanishing component.
E. Fernández-Cara +7 more
core +1 more source
Síndrome meniscal temporo maxilar
Presentado en sesión de 24 de julio de ...
Jorge de Vecchi
doaj
Zivotofsky v. Kerry: Of Passports, Politics, and Foreign Policy Powers [PDF]
This commentary profiles the upcoming Supreme Court decision in Zivotofsky v. Kerry, which will decide, for the first time in United States history, the dividing line between legislative and executive authority to recognize foreign nations.
Grand, Cara J.
core +1 more source
Financial innovation and monetary policy effectiveness [PDF]
Monetary policy - United States ; Money ...
Cara S. Lown
core
Re-using features of English as a foreign language (EFL) materials for special needs students of the same age group [PDF]
This paper identifies a lack of age-appropriate literacy software for dyslexic teenagers in Irish classrooms and investigates the features of English as a Foreign Language (EFL) software that could be helpful to dyslexic students.
Greene, Cara N.
core
ABSTRACT Background/Objective 3D printed materials have been evaluated for fabricating mouthguards; however, little is known about their biomechanical performance in preventing dental trauma. This study aimed to compare two 3D printed polymers and three ethylene vinyl acetate (EVA) sheets used for mouthguard fabrication regarding their mechanical ...
Airin Karelys Avendaño Rondon +6 more
wiley +1 more source
Quiste dentífero del maxilar inferior
Sesión del 4 de Julio de 1934.
Diego Lamas, C. M. Barberousse
doaj
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin +24 more
wiley +1 more source

